Literature DB >> 20635981

Why current peptide-based cancer vaccines fail: lessons from the three Es.

Mogens H Claesson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20635981     DOI: 10.2217/imt.09.35

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  3 in total

Review 1.  Biomaterials for vaccine-based cancer immunotherapy.

Authors:  Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal:  J Control Release       Date:  2018-10-09       Impact factor: 9.776

Review 2.  Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines.

Authors:  Dixita Ishani Viswanath; Hsuan-Chen Liu; David P Huston; Corrine Ying Xuan Chua; Alessandro Grattoni
Journal:  Biomaterials       Date:  2021-11-30       Impact factor: 12.479

3.  Computational prediction of immunodominant antigenic regions & potential protective epitopes for dengue vaccination.

Authors:  Karthikeyan Muthusamy; Krishnasamy Gopinath; Dharmalingam Nandhini
Journal:  Indian J Med Res       Date:  2016-10       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.